%0 Journal Article %A Nhan Phuc Thanh Nguyen %A Tuyen Dinh Hoang %A Vi Thao Tran %A Cuc Thi Vu %A Joseph Nelson Siewe Fodjo %A Robert Colebunders %A Michael P. Dunne %A Van Thang Vo %T Preventive behavior of Vietnamese people in response to the COVID-19 pandemic %D 2020 %R 10.1101/2020.05.14.20102418 %J medRxiv %P 2020.05.14.20102418 %X We sought to evaluate the adherence of Vietnamese adults to COVID-19 preventive measures, and gain insight into the effects of the epidemic on the daily lives of Vietnamese people. An online questionnaire survey was organized from March 31 to April 6, 2020. The questionnaire assessed preventive behavior using multiple-answer responses to indicate the extent of adherence. In total, 2175 respondents completed the questionnaire (age range: 18–69 years). The mean adherence scores for personal and community preventive measures were 7.23 ± 1.63 (range 1–9) and 9.57 ± 1.12 (range 1–11), respectively. Perceived adaptation of the community to lockdown (β=2.64, 95% CI 1.25–4.03), fears/worries concerning one’s health (β=2.87, 95% CI 0.04–5.70), residing in large cities (β=19.40, 95% CI 13.78–25.03), access to official COVID-19 information sources (β=16.45, 95% CI 6.82–26.08), and belonging to the healthcare sector (β=22.53, 95% CI 16.00–29.07) were associated with a higher adherence score to anti-COVID instructions. The study indicates excellent preventive behavior of the Vietnamese population which explains the low number of COVID-19 infections and zero recorded mortality up to the first week of May 2020. Further monitoring is recommended to assess the sustainability of COVID-19 prevention via behavior change in the medium and long-term.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study received financial support from the Institute for Community Health Research, University of Medicine and Pharmacy, Hue University and Global Health Institute, University of Antwerp, BelgiumAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data in the manuscript is available at request %U https://www.medrxiv.org/content/medrxiv/early/2020/05/20/2020.05.14.20102418.full.pdf